HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flora Peyvandi Selected Research

Respiratory Insufficiency (Respiratory Failure)

11/2022Detailed stratified GWAS analysis for severe COVID-19 in four European populations.
6/2022Use of high flow nasal cannula in patients with acute respiratory failure in general wards under intensivists supervision: a single center observational study.
2/2021Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
10/2020Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Flora Peyvandi Research Topics

Disease

95Hemorrhage
05/2024 - 05/2002
88Hemophilia A (Haemophilia)
04/2024 - 05/2002
38Thrombotic Thrombocytopenic Purpura
02/2024 - 04/2003
26Thrombosis (Thrombus)
02/2024 - 09/2005
25COVID-19
05/2024 - 01/2020
20Afibrinogenemia (Fibrinogen Deficiency)
03/2024 - 08/2002
17von Willebrand Diseases (von Willebrand's Disease)
10/2023 - 07/2011
14acquired Thrombotic thrombocytopenic purpura
01/2021 - 08/2005
13Thrombotic Microangiopathies
12/2023 - 04/2003
11Thrombocytopenia (Thrombopenia)
08/2022 - 11/2004
10Venous Thrombosis (Deep-Vein Thrombosis)
10/2022 - 02/2012
8Infections
05/2024 - 01/2007
8Venous Thromboembolism
09/2023 - 08/2013
8Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 04/2009
8Myocardial Infarction
11/2022 - 08/2006
8Thrombophilia
01/2022 - 07/2005
7Fibrosis (Cirrhosis)
03/2024 - 07/2014
7Pneumonia (Pneumonitis)
02/2024 - 08/2013
7Type 3 von Willebrand Disease
07/2023 - 05/2003
7Inflammation (Inflammations)
05/2023 - 02/2016
6Hemophilia B (Haemophilia B)
01/2024 - 05/2015
6Stroke (Strokes)
01/2020 - 02/2010
5Hemarthrosis
03/2024 - 01/2020
5Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 01/2015
5Hypertension (High Blood Pressure)
01/2023 - 04/2016
5Hemolytic Anemia
01/2019 - 11/2004
4Joint Diseases (Joint Disease)
03/2024 - 01/2021
4Spontaneous Abortion (Miscarriage)
03/2023 - 11/2014
4Liver Cirrhosis (Hepatic Cirrhosis)
12/2022 - 08/2007
4Respiratory Insufficiency (Respiratory Failure)
11/2022 - 10/2020
4Genetic Predisposition to Disease (Genetic Predisposition)
10/2020 - 08/2010
4Inherited Blood Coagulation Disorders
02/2019 - 09/2004
3Neoplasms (Cancer)
01/2024 - 04/2003
3Type 2 von Willebrand Disease
08/2023 - 03/2023
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
06/2023 - 08/2005
3Body Weight (Weight, Body)
01/2023 - 12/2009
3Sepsis (Septicemia)
05/2022 - 02/2010
3Menorrhagia
01/2020 - 07/2009
3Ischemic Stroke
01/2016 - 08/2010
3Familial Multiple Coagulation Factor Deficiency I
06/2009 - 08/2005
3Factor V Deficiency
10/2008 - 01/2003
2Synovitis
03/2024 - 10/2022

Drug/Important Bio-Agent (IBA)

55Factor VIII (Coagulation Factor VIII)IBA
04/2024 - 05/2002
39von Willebrand FactorIBA
10/2023 - 04/2003
33thiamine triphosphorate (TTP)IBA
08/2023 - 04/2003
31Fibrinogen (Factor I)FDA Link
03/2024 - 08/2002
23emicizumabIBA
04/2024 - 01/2019
22Blood Coagulation Factors (Coagulation Factor)IBA
03/2024 - 10/2002
15AntibodiesIBA
12/2023 - 08/2005
14ThrombinFDA Link
09/2022 - 10/2002
13Hemostatics (Antihemorrhagics)IBA
03/2024 - 02/2012
12AnticoagulantsIBA
01/2024 - 12/2012
12AutoantibodiesIBA
11/2023 - 11/2004
11Factor V (Coagulation Factor V)IBA
11/2019 - 10/2002
10Proteins (Proteins, Gene)FDA Link
01/2024 - 08/2005
9AntigensIBA
01/2024 - 04/2003
9Biomarkers (Surrogate Marker)IBA
08/2023 - 02/2008
9Metalloproteases (Metalloproteinases)IBA
10/2020 - 08/2005
7Monoclonal AntibodiesIBA
11/2023 - 12/2016
7caplacizumabIBA
08/2023 - 01/2016
7Prothrombin (Factor II)IBA
01/2023 - 08/2002
7DisintegrinsIBA
10/2020 - 08/2005
7ThrombospondinsIBA
10/2020 - 08/2005
7Factor X (Stuart Factor)IBA
01/2020 - 10/2002
6Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
05/2024 - 10/2016
6VaccinesIBA
01/2024 - 10/2021
6BESIBA
07/2023 - 01/2018
6fibrin fragment D (D-dimer)IBA
05/2023 - 01/2020
6Vitamin KFDA Link
01/2023 - 06/2009
6ADAMTS13 ProteinIBA
01/2019 - 04/2003
5Complement System Proteins (Complement)IBA
11/2021 - 11/2012
5DNA (Deoxyribonucleic Acid)IBA
01/2018 - 07/2005
4Valoctocogene RoxaparvovecIBA
04/2024 - 01/2023
4Factor IX (Coagulation Factor IX)FDA LinkGeneric
01/2024 - 09/2004
4COVID-19 VaccinesIBA
11/2023 - 01/2021
4C-Reactive ProteinIBA
05/2023 - 02/2021
4Immunoglobulin G (IgG)IBA
06/2022 - 08/2005
4RivaroxabanIBA
01/2021 - 11/2013
4NucleotidesIBA
01/2021 - 01/2016
4CoagulantsIBA
01/2021 - 07/2012
4EnzymesIBA
11/2019 - 08/2005
4Factor XI (Plasma Thromboplastin Antecedent)IBA
01/2017 - 05/2002
4Factor VII (Proconvertin)IBA
07/2011 - 10/2002
3AntithrombinsIBA
03/2024 - 08/2013
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2024 - 01/2021
3Ferritins (Ferritin)IBA
05/2023 - 02/2021
3OpiumIBA
01/2023 - 04/2016
3Factor XIII (Coagulation Factor XIII)IBA
01/2023 - 01/2004
3FibrinIBA
01/2022 - 10/2016
3Neutralizing AntibodiesIBA
01/2017 - 01/2016
3omega-Chloroacetophenone (Mace)IBA
10/2016 - 01/2015
3Dronabinol (THC)FDA LinkGeneric
10/2016 - 01/2015
3Protein CIBA
07/2014 - 08/2013
3Peptide Hydrolases (Proteases)FDA Link
02/2008 - 04/2003
3BBeta fibrinogenIBA
10/2003 - 08/2002
2Adenosine Triphosphate (ATP)IBA
03/2024 - 02/2016
2fitusiranIBA
03/2024 - 01/2023

Therapy/Procedure

53Therapeutics
05/2024 - 12/2008
3Injections
01/2023 - 11/2015
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2016 - 01/2013